These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 10555033

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
    Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Seibold JR.
    Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
    [Abstract] [Full Text] [Related]

  • 3. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
    Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen VD, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Furst DE.
    Arthritis Rheum; 2000 Nov; 43(11):2445-54. PubMed ID: 11083267
    [Abstract] [Full Text] [Related]

  • 4. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WK, Hurwitz EL, Mayes M, White B, Wigley F, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ.
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A cross-sectional comparison of three self-reported functional indices in scleroderma.
    Smyth AE, MacGregor AJ, Mukerjee D, Brough GM, Black CM, Denton CP.
    Rheumatology (Oxford); 2003 Jun; 42(6):732-8. PubMed ID: 12730528
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
    Johnson SR, Glaman DD, Schentag CT, Lee P.
    J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Using a self-reported functional score to assess disease progression in systemic sclerosis.
    Serednicka K, Smyth AE, Black CM, Denton CP.
    Rheumatology (Oxford); 2007 Jul; 46(7):1107-10. PubMed ID: 17426141
    [Abstract] [Full Text] [Related]

  • 13. Does incorporation of aids and devices make a difference in the score of the health assessment questionnaire-disability index? Analysis from a scleroderma clinical trial.
    Khanna D, Clements PJ, Postlethwaite AE, Furst DE.
    J Rheumatol; 2008 Mar; 35(3):466-8. PubMed ID: 18085737
    [Abstract] [Full Text] [Related]

  • 14. The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
    Sekhon S, Pope J, Canadian Scleroderma Research Group, Baron M.
    J Rheumatol; 2010 Mar; 37(3):591-8. PubMed ID: 20080913
    [Abstract] [Full Text] [Related]

  • 15. Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey.
    Mouthon L, Rannou F, Bérezné A, Pagnoux C, Guilpain P, Goldwasser F, Revel M, Guillevin L, Fermanian J, Poiraudeau S.
    Arthritis Rheum; 2008 Jul 15; 59(7):968-73. PubMed ID: 18576298
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Results of the Health Assessment Questionnaire for Japanese patients with systemic sclerosis--measuring functional impairment in systemic sclerosis versus other connective tissue diseases.
    Morita Y, Muro Y, Sugiura K, Tomita Y, Tamakoshi K.
    Clin Exp Rheumatol; 2007 Jul 15; 25(3):367-72. PubMed ID: 17631731
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of pain in health related quality of life of patients with systemic sclerosis.
    Georges C, Chassany O, Toledano C, Mouthon L, Tiev K, Meyer O, Ilie D, Rambeloarisoa J, Marjanovic Z, Cabane J, Sereni D, Pouchot J, Farge D.
    Rheumatology (Oxford); 2006 Oct 15; 45(10):1298-302. PubMed ID: 16754629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.